Kite Pharma · 1 day ago
Senior Director, Global Commercial Strategy, Lymphoma
Santa Monica, CA
Full-time
Onsite
Director/Executive
$238K/yr - $307K/yr
7+ years expKite Pharma is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The Senior Director, Global Commercial Strategy for Lymphoma will be pivotal in shaping the future of cell therapy in lymphoma, driving brand strategy and execution for new and existing products while leading the Global Commercial Strategy Lymphoma team.
BiotechnologyHealth CareMedicalOncologyTherapeutics
Responsibilities
Lead the development of the Lymphoma Integrated Strategic Planning (ISP) and the associated Plan of Action, working in close collaboration with all the functions
Serve as the marketing product team member (PTM) for the NextGen Lymphoma Product Team (PT), bringing the voice of the customer into the development plan
Lead the GCS Lymphoma team, providing strategic direction and oversight to the Yescarta & Tecartus Global Commercial Strategy Director and the Lymphoma Global Commercial Strategy Senior Manager / Associate Director
Co-lead the Lymphoma Global Brand Team in partnership with the Global Medical Affairs and Value & Access lead for Lymphoma driving cross-functional alignment to ensure cohesive strategy and tactic execution
Act as the brand champion for Lymphoma NextGen Asset, collaborating with internal and external stakeholders to ensure optimal global commercialization
Analyze the lymphoma disease landscape and competitive environment, distilling insights to support a differentiated brand strategy
Develop and nurture collaborations that drive business objectives, including partnerships with global regions and external organizations
Lead the development of global strategic launch plans for Kite’s Lymphoma NextGen Asset, maximizing brand value at launch and supporting long-term performance
Qualification
Required
Ph.D. and 7 Years' Experience OR
Master's Degree and 10 Years' Experience OR
Bachelor's Degree and 12 Years' Experience
Preferred
Proven experience in pharmaceutical global strategic marketing, with a focus on commercial partnerships and product launches in hematology and/or cell therapy
Experience executing key brand deliverables at country or regional level
Strong leadership skills within large, matrixed organizations; ability to navigate complex business structures
Resilient profile with the ability to deliver in an ambiguous environment and complex matrix
Ability to collaborate effectively with cross-functional partners (clinical, medical, tech-ops, regulatory, etc.) to shape program strategy
Experience in hematology and in the lymphoma space is highly desirable
Approachable and credible communication style, both verbally and written, to keep all levels of the organization informed and engaged
Ability to engage and manage multiple stakeholders, including senior executives
Curious, with learning agility and a drive for excellence and high-quality deliverables
Organized with a systematic approach to prioritization
Role model of Kite/Gilead core values, inspiring a high-performance culture and engagement
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Kite Pharma
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.
1001-5000 employees
H1B Sponsorship
Kite Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (47)
2023 (54)
2022 (59)
2021 (53)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$335.38MKey Investors
Alta Partners
2017-08-28Acquired
2015-12-10Post Ipo Equity· $250.12M
2014-06-20IPO
Leadership Team
Mark Jurgens
Vice President, Global Head of Evidence Generation & Strategic Collaborations
Craig Vermeyen
Director, Packaging and Labeling
Recent News
BioWorld Financial Watch
2025-12-29
2025-12-07
Company data provided by crunchbase